Day: February 25, 2021

ORLANDO, Fla., Feb. 25, 2021 (GLOBE NEWSWIRE) — Today, we are pleased to introduce a new featured company, and one that is making news in the battle against COVID-19 due to recent achievements for the Company’s technology in the critical diagnostic market.XPhyto Therapeutics Corp. (XPHYF), which is listed in the United States, Canada, and Germany is also involved in CBD, THC and Psychedelics. A discussion of those lucrative markets will be for another missive as we discuss the breaking news about the Company’s rapid tests for COVID-19.Let’s start with the headline:“XPhyto Builds Commercial Team to Launch 25-Minute Covid-19 RT-PCR Test”Here’s what you need to know.The Company has expedited the formation of an experienced commercial team to launch its point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system (“Covid-ID Lab”)...

– SK and Plug Power had a virtual signing ceremony, setting the stage for successful joint projects to come including forming a JV– Through a JV in Asia, the two companies are set to establish a fuel cell factory and accelerate the expansion into Asian markets including ChinaLATHAM, N.Y., Feb. 25, 2021 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a leading provider of turnkey hydrogen solutions building the global green hydrogen economy, and SK Group, one of the leading South Korean business groups, announce the completion of the $1.6 billion capital investment to partner in accelerating hydrogen as an alternative energy source in Asian markets. In celebration of kicking off the new partnership, including a plan to form a joint venture company in Asia, the executives of SK and Plug Power had a virtual deal closing...

SCOTTSDALE, Ariz., Feb. 25, 2021 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ:JYNT), a national operator, manager, and franchisor of chiropractic clinics, announced that management plans to present and conduct one-on-one meetings at these conferences in March 2021.DA Davidson 4thAnnual Consumer Growth ConferencePresentation: Thursday, March 11th at 10:15 a.m. PT / 1:15 p.m. ETVirtual 1×1 meetings March 11th33rdAnnual ROTH ConferencePresentation: Wednesday, March 17th at 7:00 a.m. PT / 10:00 a.m. ETVirtual 1×1 meetings March 15th – 17thPresentation materials will be posted on the Investor Relations portion of the company’s website. Interested parties may contact their representatives at the above firms to arrange meetings at the respective events.About The Joint ChiropracticThe Joint Corp. revolutionized access to chiropractic...

Nasal spray may offer room temperature distribution that could reduce logistical challenges for healthcare systems and providersIntranasal administration targets the virus at its point of entry and in a preclinical study induced local nasal mucosal immunity believed to be critical for preventing further viral transmissionGAITHERSBURG, Md., Feb. 25, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it has commenced enrollment in a Phase 1 clinical trial of AdCOVID, a single-dose intranasal COVID-19 vaccine candidate. AdCOVID is an adenovirus-vector vaccine designed to stimulate a broad immune response including both systemic immunity (neutralizing antibody) and local immunity (mucosal IgA and resident memory T cells) in the nasal cavity and respiratory tract.The...

Phase 2/3 pivotal Illuminate trial of sepofarsen for LCA10 enrollment complete with top-line data anticipated in H1 2022; Brighten pediatric trial of sepofarsen to begin in 2021; additional data from Phase 1/2 InSight extension study to be reported in H2 2021QR-421a Stellar Phase 1/2 trial for Usher syndrome and non-syndromic retinitis pigmentosa interim analysis on track for late Q1/early Q2 2021Further pipeline progress anticipated with first clinical data in 2021 from QR-1123 program for autosomal dominant retinitis pigmentosa and QR-504a clinical study in Fuchs endothelial corneal dystrophy expected to start in H1 2021Cash runway into 2023LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation...

EEZY OYJ  —  STOCK EXCHANGE RELEASE  —  25 FEBRUARY 2021 AT 14.00Correction to the estimated capital gain from divestment in SwedenEezy announced in December 2020 that it will sell its Swedish subsidiary VMP-Group Sweden AB. The transaction was completed in January 2021.When the final accounting of the divestment was prepared, an error in calculation of the initial estimate of the capital gain was noted. Instead of the earlier estimates of 1.5-1.7 million euro, the capital gain in the consolidated financials will be approx. 0.1 million euro. In addition, approx. 0.2 million euro of related costs will be booked.The original statement that the transaction is not estimated to cause any significant change to Eezy’s balance sheet or future profitability, is still valid.For further information, please contact:Hannu NymanCFOhannu.nyman@eezy.fitel....

EEZY OYJ  —  PÖRSSITIEDOTE  —  25.2.2021 KLO 14.00Korjaus arvioon Ruotsin tytäryhtiön kirjanpidollisesta myyntivoitostaEezy tiedotti joulukuussa 2020, että se myy Ruotsin tytäryhtiönsä VMP-Group Sweden AB:n. Kauppa toteutui tammikuussa 2021.Laadittaessa lopullista laskelmaa myynnin kirjanpidollisesta vaikutuksesta on havaittu virhe myyntivoiton alustavan arvion laskennassa. Aiempien arvioiden 1,5-1,7 miljoonan euron asemesta myyntivoitoksi konsernituloslaskelmassa muodostuu noin 0,1 miljoonaa euroa. Tämän lisäksi tuloslaskelmaan kirjautuu noin 0,2 miljoona euroa kuluja.Alkuperäinen arvio siitä, että yrityskaupalla ei arvioida olevan merkittävää vaikutusta Eezyn taseeseen tai tulevaan tuloskehitykseen pitää edelleen paikkansa.Lisätietoja:Hannu Nymantalousjohtajahannu.nyman@eezy.fipuh. +358 (0)50 306 9913

BLUE BELL, Pa., Feb. 25, 2021 (GLOBE NEWSWIRE) — REGO Payment Architectures, Inc. (“REGO”) (OTCQB:RPMT), provider of an all digital-based service allowing children to make purchases anytime, from anywhere using their mobile devices, today announced MazoolaSM is now available in the Google Play Store.Our MazoolaSM Digital Family Wallet, COPPA compliant technology is now available for Android devices.  With the same features as our iPhone version, MazoolaSM provides parents a safe and user friendly app on the Android platform. Parents and children with Android devices greater than version 7 are now able to download MazoolaSM from the Google Play Store.  Peter S. Pelullo, CEO, stated “With this latest development, MazoolaSM is able to address nearly 100% of the mobile market.”A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6eefe00b-f493-4e92-a919-390876d09b6chttps://gs.statcounter.com/os-market-share/mobile/united-states-of-america Safe...